share_log

RBC Capital Upgrades Amgen to Outperform, Raises Price Target to $300

Benzinga ·  Dec 12, 2023 05:52

RBC Capital analyst Gregory Renza upgrades Amgen (NASDAQ:AMGN) from Sector Perform to Outperform and raises the price target from $256 to $300.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment